Clin2Atlas
AtlasDigestiveDigestive diseases

Vascular intestinal disorders

3Curable in someAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

What's being tested now

2000: 4 trials started2001: 2 trials started2002: 3 trials started2003: 4 trials started2004: 2 trials started2005: 2 trials started2006: 1 trials started2007: 6 trials started2008: 5 trials started2009: 5 trials started2010: 7 trials started2011: 4 trials started2012: 13 trials started2013: 23 trials started2014: 22 trials started2015: 16 trials started2016: 26 trials started2017: 41 trials started2018: 48 trials started2019: 88 trials started2020: 126 trials started2021: 186 trials started2022: 257 trials started2023: 429 trials started2024: 691 trials started2025: 921 trials started2026: 865 trials started2000201020202026921

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

See all 3605 active Adenocarcinoma of the Rectum trials on Clin2 →

Related

AppendicitisParalytic ileus and intestinal obstructionInguinal, femoral, and abdominal herniaInflammatory bowel diseaseGallbladder and biliary diseasesPancreatitisOther digestive diseases

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.